COVID pill Paxlovid gets full FDA approval after more than a year of emergency use
The U.S. Food and Drug Administration on Thursday granted full approval to Pfizer's (PFE.N) oral antiviral COVID-19 treatment Paxlovid, clearing the way for the drugmaker to sell it at market rates once U.S. government supplies dwindle.
Media Miss by the Right
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below.
Learn more about this dataLeft 21%
Center 75%
Right 5%
Bias Distribution
73 other sources covering this story
Total News Sources
73
Leaning Left
14
Center
50
Leaning Right
3
Last Updated
11 months ago
Bias Distribution Powered by Ground News™
More Media Misses
Media Misses by the Left
Media Misses
by the Right
Powered by Ground News™
Latest SAN Stories
-
AP Images
Argentina asks to join NATO as Milei looks to enhance security, strengthen ties
-
Getty Images
Utah students protest 'furries,' school admin deny problem
-
Reuters/Jane Rosenberg
Trump’s ‘hush money’ trial: Legal experts debate name coined by media.
-
AP Images
Black Chicagoans feel neglected as millions funneled to migrant crisis